Page last updated: 2024-08-23

nicorandil and Chemical and Drug Induced Liver Injury, Chronic

nicorandil has been researched along with Chemical and Drug Induced Liver Injury, Chronic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Abdelzaher, WY; El-Hussieny, M; Refaie, MMM; Shehata, S; Welson, NN1

Other Studies

1 other study(ies) available for nicorandil and Chemical and Drug Induced Liver Injury, Chronic

ArticleYear
Exploring the role of ATP-sensitive potassium channel, eNOS, and P-glycoprotein in mediating the hepatoprotective activity of nicorandil in methotrexate-induced liver injury in rats.
    Immunopharmacology and immunotoxicology, 2023, Volume: 45, Issue:5

    Topics: Adenosine Triphosphate; Animals; Antioxidants; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caspase 3; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; KATP Channels; Liver; Male; Methotrexate; Nicorandil; Nitric Oxide Synthase Type III; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase

2023